NCT01938833 2025-05-16Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerThomas Jefferson UniversityPhase 1/2 Terminated9 enrolled 7 charts
NCT00104884 2023-06-28FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant MelanomaEastern Cooperative Oncology GroupPhase 2 Terminated4 enrolled 4 charts
NCT00765102 2019-11-25Trial of Romidepsin and Bortezomib for Multiple MyelomaCelgenePhase 2 Terminated32 enrolled 14 charts